• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Chondroitin helps arthritis of the knee

Chiropractic Economics February 10, 2009

Long-term use of prescription-grade chondroitin sulfate for treatment of knee arthritis reduces pain and slows joint narrowing, investigators report in the journal Arthritis & Rheumatism.

The Study on Osteoarthritis Progression Prevention (STOPP) involved 622 patients in Europe and the US, ages 45-80 years, with knee arthritis. On average, the patients reported moderate levels of pain when the study began.

Patients were randomly assigned to 2 years of daily treatment with chondroitin or inactive “placebo.” X-rays of the affected knee were taken to assess the impact of treatment.

Pain relief increased with time in the chondroitin group, lead author Dr. Andre Kahan, at Cochin Hospital in Paris, and colleagues report. Moreover, treatment with chondroitin reduced the likelihood of joint narrowing — indicating a loss of cartilage — by 33 percent.

Over 90 percent of the subjects reported good or very good tolerability with chondroitin, and side effects were no more likely than with placebo.

The authors note that because the chondroitin used in the STOPP trial is a prescription drug, the results cannot be generalized to chondroitin products sold as dietary supplements.

SOURCE: Arthritis & Rheumatism, February 2009.

Related Posts

  • Vitamin B12 supplements may help treat hepatitis CVitamin B12 supplements may help treat hepatitis C
  • Fish oil supplements cut adiposity in type 2 diabeticsFish oil supplements cut adiposity in type 2 diabetics
  • Boron: good for your bones and moreBoron: good for your bones and more
  • Omega-3 may ease depression during pregnancyOmega-3 may ease depression during pregnancy
  • Clinical study confirms effectiveness of glucosamine hydrochloride and chondroitin sulfate combination in supporting joint healthClinical study confirms effectiveness of glucosamine hydrochloride and chondroitin sulfate combination in supporting joint health
  • BCM-95 curcumin and BosPure boswellia compared to arthritis drugBCM-95 curcumin and BosPure boswellia compared to arthritis drug

Filed Under: News, Nutrition Supplements News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Logan University debuts new health center
    Logan University logo
  • Foot Levelers releases spring 2021 seminars schedule
  • MediHerb® introduces Ashwagandha Forte for patient sleep, stress, immunity support